In vivo experiments confirm these effects, with tumor growth suppression significantly attenuated in LKB1 knockdown models, emphasizing LKB1’s centrality in the CO-mediated antitumor response (Loboda et al., 2015; Yan et al., 2018). The gene discussed is STK11; the disease is neoplasm.